Loss of heterozygosity at the mannose 6-phosphate/insulin-like growth factor 2 receptor locus: a frequent but late event in adrenocortical tumorigenesis
S. Leboulleux et al., Loss of heterozygosity at the mannose 6-phosphate/insulin-like growth factor 2 receptor locus: a frequent but late event in adrenocortical tumorigenesis, EUR J ENDOC, 144(2), 2001, pp. 163-168
Objective: Recent studies have pointed to the role of the IGF system in adr
enocortical tumorigenesis. The IGF-II gene is overexpressed in malignant ad
renocortical tumors and its proliferative effects are mediated by the type-
1 IGF receptor (IGF1R). The mannose 6-phosphate/IGF2 receptor (M6P/IGF2R) p
lays a key role in regulating cell growth, by ensuring the clearance and in
activation of IGF-II and facilitating activation of the growth inhibitor. t
ransforming growth factor beta (TGF beta1). The M6P/IGF2R has been implicat
ed as a tumor suppressor gene in various human tumors.
Methods: The purpose of this study was to determine if the M6P/IGF2R is inv
olved in adrenal tumorigenesis. Two polymorphisms in the 3' untranslated re
gion of M6P/IGF2R were used to screen a large series of 76 sporadic adrenoc
ortical tumors for loss of heterozygosity (LOH) by PCR amplification of DNA
. Tumors were classified into three groups based on pathological features:
benign tumors (n = 25), suspect tumors (n = 22) and malignant tumors (n = 2
9).
Results: LOH at the M6P/IGF2R locus was detected in 15 of 57 (26%) informat
ive tumors and was more frequent in malignant tumors (58%) than in benign a
nd suspect tumors (9 and 13% respectively).
Conclusion: These findings provide evidence that LOH at the M6P/IGF2R locus
is a frequent event in adrenocortical tumors and support the hypothesis th
at it may function as a tumor suppressor gene in adrenocortical tumorigenes
is.